Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.33 |
| ▸ | MMP9 | P14780 | 4/20 | 0.33 |
| ▸ | MMP8 | P22894 | 4/20 | 0.33 |
| ▸ | MMP13 | P45452 | 4/20 | 0.33 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2416793 | 1.00 | MMP2 (0.33) | MMP2MMP9MMP8MMP13GPR35 | |
| SCHEMBL30120697 | 1.00 | MMP2 (0.33) | MMP2MMP9MMP8MMP13GPR35 | |
| SCHEMBL15249151 | 0.98 | MMP2 (0.33) | MMP2MMP9MMP8MMP13GPR35 | |
| SCHEMBL21485095 | 0.93 | MMP2 (0.31) | MMP2MMP9MMP8MMP13 | |
| SCHEMBL31296502 | 0.89 | MMP2 (0.37) | MMP2MMP9MMP8MMP13GPR35 | |
| SCHEMBL1172970 | 0.89 | MMP2 (0.37) | MMP2MMP9MMP8MMP13GPR35 | |
| SCHEMBL1421162 | 0.89 | MMP2 (0.37) | MMP2MMP9MMP8MMP13GPR35 | |
| SCHEMBL14243565 | 0.89 | MMP2 (0.37) | MMP2MMP9MMP8MMP13GPR35 | |
| SCHEMBL993128 | 0.89 | MMP2 (0.37) | MMP2MMP9MMP8MMP13GPR35 | |
| SCHEMBL9982961 | 0.87 | MMP2 (0.35) | MMP2MMP9MMP8MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250040423-A1 | NOVEL COMPOUNDS | FLEXENABLE TECHNOLOGY LTD (¿¿¿¿¿¿¿¿¿¿¿¿) (GB) | 2025-01-30 | — | — | US | disclosed |
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | CLAP CO., LTD. (KR) | 2023-10-03 | — | — | US | disclosed |
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | CLAP CO., LTD. (KR) | 2023-10-03 | — | — | US | disclosed |
| WO-2023105209-A1 | NOVEL COMPOUNDS | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2023-06-15 | — | — | WO | disclosed |
| US-11289663-B2 | Organic semiconducting compounds | Raynergy Tek Incorporation (TW) | 2022-03-29 | — | — | US | disclosed |
| US-20210384434-A1 | INDACENO DERIVATIVES AS ORGANIC SEMICONDUCTORS | CLAP CO., LTD. (KR) | 2021-12-09 | — | — | US | disclosed |
| US-20200373502-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | Raynergy Tek Incorporation (TW) | 2020-11-26 | — | — | US | disclosed |
| WO-2020078815-A1 | INDACENO DERIVATIVES AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2020-04-23 | — | — | WO | disclosed |
| US-10547004-B2 | Organic semiconductors | MERCK PATENT GMBH (DE) | 2020-01-28 | — | — | US | disclosed |
| US-20150255725-A1 | ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2015-09-10 | — | — | US | disclosed |
| US-9017577-B2 | Indacenodithiophene and indacenodiselenophene polymers and their use as organic semiconductors | MERCK PATENT GMBH (DE) | 2015-04-28 | — | — | US | disclosed |
| US-9017577-B2 | Indacenodithiophene and indacenodiselenophene polymers and their use as organic semiconductors | MERCK PATENT GMBH (DE) | 2015-04-28 | — | — | US | disclosed |
| EP-2315793-B1 | INDACENODITHIOPHENE AND INDACENODISELENOPHENE POLYMERS AND THEIR USE AS ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2013-08-21 | — | — | EP | disclosed |
| US-20110226999-A1 | Indacenodithiophene and Indacenodiselenophene Polymers and their Use as Organic Semiconductors | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG | 2011-09-22 | — | — | US | disclosed |
| US-20110226999-A1 | Indacenodithiophene and Indacenodiselenophene Polymers and their Use as Organic Semiconductors | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG | 2011-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210384434-A1 | INDACENO DERIVATIVES AS ORGANIC SEMICONDUCTORS | IPO11, CYP1B1, IDO1 | MMP2 4820/4885MMP9 3361/4885MMP8 4795/4885 |
| US-11289663-B2 | Organic semiconducting compounds | OCIAD2, PORCN, SQLE | MMP2 4863/4885MMP9 3991/4885MMP8 4856/4885 |
| US-10547004-B2 | Organic semiconductors | OCIAD2, OCIAD1, OR10J3 | MMP2 4860/4885MMP9 4751/4885MMP8 4881/4885 |
| US-20200373502-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | OCIAD2, PORCN, SQLE | MMP2 4863/4885MMP9 3991/4885MMP8 4856/4885 |
| US-20150255725-A1 | ORGANIC SEMICONDUCTORS | OCIAD2, OCIAD1, OR10J3 | MMP2 4860/4885MMP9 4751/4885MMP8 4881/4885 |
| US-20110226999-A1 | Indacenodithiophene and Indacenodiselenophene Polymers and their Use as Organic Semiconductors | ICMT, TST, INMT | MMP2 4817/4885MMP9 4485/4885MMP8 4864/4885 |
| US-11778893-B2 | Indaceno derivatives as organic semiconductors | IPO11, CYP1B1, IDO1 | MMP2 4820/4885MMP9 3361/4885MMP8 4795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.